Search results
Results From The WOW.Com Content Network
Although the latest news from the laboratory was mixed for pharmaceutical company Sanofi (NASDAQ: SNY) on Tuesday, investors gave the company the benefit of the doubt. They bid the share price up ...
By Ludwig Burger (Reuters) -Sanofi stock plunged on Friday, wiping 20 billion euros ($21 billion) off its market value, after it abandoned its 2025 profit target under a plan to list its consumer ...
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Science & Tech. Shopping. Sports
Let's see if Sanofi (SNY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Paris-based Sanofi (NYSE:SNY) beat analyst estimates in its earnings for Q2. Now, with new drugs coming into the market, SNY stock could be poised for a recovery. This missed Wall Street estimates ...
Novavax stock skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi would invest $1.2 billion in a deal for Novavax's COVID-19 vaccine and take a minority stake ...
Sanofi struck a $5.2 billion deal with Exscientia, a cancer biotech; made a $1.2 billion deal with Atomwise, an AI drug discovery company; and invested $180 million in French startup Owkin, also ...